Skip to content

Virtual reality as a treatment for alcohol use disorder

Virtual reality as a treatment for alcohol use disorder - VR as a treatment for alcohol use disorder

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON51954
Enrollment
10
Registered
2022-06-13
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Middelgerelateerde en verslavingsstoornissen alcohol addiction Alcohol use disorder

Interventions

During the VR CET participants will receive an hour of VR CET twice a week for 5 subsequent weeks, 10 hours in total. The regular CBT protocol for addiction care will be used as a guideline, in whic

Sponsors

Parnassia (Den Haag)
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Alcohol use disorder

Exclusion criteria

Exclusion criteria: Severe interfering psychiatric disorders (acute mood disorders, acute psychotic disorders and neuropsychiatric disorders).

Design outcomes

Primary

MeasureTime frame
The main parameter is subjective craving. Subjective craving will be measured with questionnaires and participants will be asked to fill in the ASI, Mate CRIMI: verlangen and VAS before each treatment session. After the treatment session participants will be asked to fill in the VAS again. Three months after the last session participants will be asked to answer all the questionnaires mentioned above once more.

Secondary

MeasureTime frame
Secondary parameter will be physiological craving and self-efficacy, measured by self-report. The non-invasive physiological measures are heart rate variability and skin conductance, which will be measured with the Biopac software. Third, after each virtual reality session, participants will be asked to fill in the therapy evaluation scale to investigate how participants experienced the virtual reality cue exposure therapy. Also, alcohol relapse will be monitored through self-report and routine urine drug monitoring.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)